CD248 and renal cell carcinoma: The similar prognostic value of CD248+ CAFs in the two major subtypes of RCC (i.e., clear-cell RCC and papillary RCC) were further validated in TCGA-KIRC and KIRP cohorts (p < 0.01, Figures S4A, B).